PH
IXICO plc
PHYOF · OTC
$0.07 +0.00% (+$0.00)
Market Cap £4.82M
P/E Ratio -
Div. Yield -
ROE 14.93%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.74x
P/B 0.41x
P/E N/A
Growth
3 /100
Declining Rev. growth 8.90%
Book val. growth 2.06%
EPS growth N/A
Profitability
19 /100
Weak Gross margin 48.71%
FCF margin 28.73%
Net margin 25.27%
Quality
6 /100
Poor ROIC 14.43%
Asset turnover 0.47x
ROE 14.93%
Debt
69 /100
Low Debt/Equity 0.02x
Int. coverage -152.06x
Current ratio 3.03x
Stability
19 /100
Unstable Beta 0.11x
Profitable years 0
Rev. volatility 18.79%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na PHYOF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Bram Goorden
Employees
79
Headquarters
London
Nadcházející události
08 PRO
Earnings
Upcoming earnings report